// App-Quantinova.ai

149 : A novel internally validated risk prediction model for adverse cardiac outcome in fabry disease

Researchers

Presenter

  • Christopher Orsborne

Principal Investigators

  • Joshua Bradley

  • Laura J Bonnett

  • Luke A Pleva

  • Josephine H Naish

  • David G Clark

  • Nik Abidin

  • Peter Woolfson

  • Gaetano Nucifora

  • Matthias Schmitt

  • Ana Jovanovic

  • Christopher A Miller

  • Anna Reid

Medical Centers

  • The Univeristy of Manchester, MCMR, Manchester University Foundation Trust, Manchester, LAN M23 9LT, United Kingdom

  • Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health,

  • Department of Health Data Science, University of Liverpool, a Member of Liverpool Health Partners

  • Manchester University NHS Foundation Trust, Southmoor Road, Wythenshawe, Manchester, M23 9LT

  • Salford Royal NHS Foundation Trust, Stott Lane, Salford, UK

Locations

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

Disease

  • Fabry disease

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Prospective

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved